Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One. 2021 Apr 23;16(4):e0248080. doi: 10.1371/journal.pone.0248080. Erratum in: PLoS One. 2021 May 13;16(5):e0251897. PMID: 33891615; PMCID: PMC8064574.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- Other Results
Journal Publication Name
- PLoS One
Literature Type
- PCORI Research